Association of caveolin-1 genotypes with gastric cancer in Taiwan

Anticancer Research

Volumn 34, Issue 5, 2014, Pages 2263-2268

  Lin, Chih Hsueh ^a,b   Lin, Cheng Chieh ^a,d   Tsai, Chia Wen ^a,b   Chang, Wen Shin ^a,c   Yang, Chuan Wei ^a   Bau, Da Tian ^a,b  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b Department of Family Medicine ^*  (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d ASIA UNIVERSITY   (Taiwan)

Author keywords

Caveolin 1; Gastric cancer; Genotype; Polymorphism

Indexed keywords

CAVEOLIN 1; CAV1 PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; CANCER RISK; CONTROLLED STUDY; EARLY DIAGNOSIS; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROTEIN FUNCTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER; TAIWAN; AGED; CAVEOLIN-1; FEMALE; GENETIC PREDISPOSITION; GENETICS; MALE; POLYMORPHISM; STOMACH TUMOR; VERY ELDERLY;

CAVEOLIN-1; GASTRIC CANCER; GENOTYPE; POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; CAVEOLIN 1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; STOMACH NEOPLASMS; TAIWAN;

EID: 84902974583     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Jemal A, Siegel R, Xu J and Ward E: Cancer statistics, 2010. CA Cancer J Clin 60: 277-300, 2010.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
3. Nagini S: Carcinoma of the stomach: A review of epidemiology, pathogenesis, molecular genetics and chemoprevention. World J Gastrointest Oncol 4: 156-169, 2012.
4. Parkin DM: The global health burden of infection-Associated cancers in the year 2002. Int J Cancer 118: 3030-3044, 2006.
5. Correa P and Piazuelo MB: Helicobacter pylori Infection and Gastric Adenocarcinoma. US Gastroenterol Hepatol Rev 7: 59-64, 2011.
6. Cohen AW, Hnasko R, Schubert W and Lisanti MP: Role of caveolae and caveolins in health and disease. Physiol Rev 84: 1341-1379, 2004.
7. Glenney JR Jr.: Tyrosine phosphorylation of a 22-kDa protein is correlated with transformation by Rous sarcoma virus. J Biol Chem 264: 20163-20166, 1989.
8. Belanger MM, Roussel E and Couet J: Caveolin-1 is down-regulated in human lung carcinoma and acts as a candidate tumor-suppressor gene. Chest 125: 106S, 2004.
9. Wiechen K, Diatchenko L, Agoulnik A, Scharff KM, Schober H, Arlt K, Zhumabayeva B, Siebert PD, Dietel M, Schafer R and Sers C: Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene. Am J Pathol 159: 1635-1643, 2001.
10. Wiechen K, Sers C, Agoulnik A, Arlt K, Dietel M, Schlag PM and Schneider U: Down-regulation of caveolin-1, a candidate tumor suppressor gene, in sarcomas. Am J Pathol 158: 833-839, 2001.
11. Kato K, Hida Y, Miyamoto M, Hashida H, Shinohara T, Itoh T, Okushiba S, Kondo S and Katoh H: Overexpression of caveolin-1 in esophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. Cancer 94: 929-933, 2002.
12. Yang G, Truong LD, Wheeler TM and Thompson TC: Caveolin-1 expression in clinically confined human prostate cancer: a novel prognostic marker. Cancer Res 59: 5719-5723, 1999.
13. Hsu CM, Yang MD, Tsai CW, Ho CY, Chang WS, Chang SC, Jeng LB, Tsai Y, Tsai FJ and Bau DT: The contribution of caveolin-1 genotype and phenotype to hepatocellular carcinoma. Anticancer Res 33: 671-677, 2013.
14. Tsou YA, Tsai CW, Tsai MH, Chang WS, Li FJ, Liu YF, Chiu CF, Lin CC and Bau DT: Association of caveolin-1 genotypes with nasopharyngeal carcinoma susceptibility in Taiwan. Anticancer Res 31: 3629-3632, 2011.
15. Chen HL, Fan LF, Gao J, Ouyang JP and Zhang YX: Differential expression and function of the caveolin-1 gene in non-small cell lung carcinoma. Oncol Rep 25: 359-366, 2010.
16. Haeusler J, Hoegel J, Bachmann N, Herkommer K, Paiss T, Vogel W and Maier C: Association of a CAV1 haplotype to familial aggressive prostate cancer. Prostate 65: 171-177, 2005.
17. Langeberg WJ, Tahir SA, Feng Z, Kwon EM, Ostrander EA, Thompson TC and Stanford JL: Association of caveolin-1 and-2 genetic variants and post-treatment serum caveolin-1 with prostate cancer risk and outcomes. Prostate 70: 1020-1035, 2010.
18. Wu HC, Chang CH, Tsou YA, Tsai CW, Lin CC and Bau DT: Significant association of caveolin-1 (CAV1) genotypes with prostate cancer susceptibility in Taiwan. Anticancer Res 31: 745-749, 2011.
19. Li T, Sotgia F, Vuolo MA, Li M, Yang WC, Pestell RG, Sparano JA and Lisanti MP: Caveolin-1 mutations in human breast cancer: functional association with estrogen receptor alpha-positive status. Am J Pathol 168: 1998-2013, 2006.
20. Liu LC, Su CH, Wang HC, Tsai CW, Chang WS, Ho CY, Wu CI, Li FJ, Lin CH, Lane HY and Bau DT: Significant association of caveolin-1 (CAV1) genotypes with breast cancer in Taiwan. Anticancer Res 31: 3511-3515, 2011.
21. Bau DT, Tsai MH, Tsou YA, Wang CH, Tsai CW, Sun SS, Hua CH, Shyue SK and Tsai RY: The association of caveolin-1 genotypes with oral cancer susceptibility in Taiwan. Ann Surg Oncol 18: 1431-1438, 2011.
22. Yang MD, Tsai RY, Liu CS, Chang CH, Wang HC, Tsou YA, Wang CH, Lin CC, Shyue SK and Bau DT: Association of caveolin-1 polymorphisms with colorectal cancer susceptibility in Taiwan. World J Gastrointest Oncol 2: 326-331, 2010.
23. Bau DT, Chang CH, Tsai RY, Wang HC, Wang RF, Tsai CW, Yao CH, Chen YS, Shyue SK and Huang CY: Significant association of caveolin-1 genotypes with bladder cancer susceptibility in Taiwan. Chin J Physiol 54: 153-160, 2011.
24. Wang CH, Lai YL, Chang WS, Wu KH, Lane HY, Chiu CF, Tsai FJ, Lin CC and Bau DT: Significant association of caveolin-1 single nucleotide polymorphisms with childhood leukemia in Taiwan. Cancer Genomics Proteomics 10: 75-79, 2013.
25. Chang WS, Tsai CW, Ji HX, Wu HC, Chang YT, Lien CS, Liao WL, Shen WC, Tsai CH and Bau DT: Associations of cyclo oxygenase 2 polymorphic genotypes with bladder cancer risk in Taiwan. Anticancer Res 33: 5401-5405, 2013.
26. Chang WS, Lin SS, Li FJ, Tsai CW, Li LY, Lien CS, Liao WL, Wu HC, Tsai CH, Shih TC and Bau DT: Significant association of caveolin-1 (CAV1) genotypes with upper urothelial tract cancer. Anticancer Res 33: 4907-4912, 2013.
27. Wang S, Jia L, Zhou H, Wang X and Zhang J: Caveolin-1 promotes the transformation and anti-Apoptotic ability of mouse hepatoma cells. IUBMB Life 60: 693-699, 2008.
28. Wang S, Jia L, Zhou H, Shi W and Zhang J: Knockdown of caveolin-1 by siRNA inhibits the transformation of mouse hepatoma H22 cells in vitro and in vivo. Oligonucleotides 19: 81-88, 2009.
29. Wang S, Yu S, Shi W, Ge L, Yu X, Fan J and Zhang J: Curcumin inhibits the migration and invasion of mouse hepatoma Hca-F cells through down-regulating caveolin-1 expression and epidermal growth factor receptor signaling. IUBMB Life 63: 775-782, 2011.